Siga Technologies (SIGA) Capital Expenditures (2010 - 2025)
Siga Technologies' (SIGA) quarterly Capital Expenditures came in at $289576.0 in Q3 2025, up 1191.19% on a YoY basis from $22427.0 in Q3 2024, and up 28957500.0% quarter-over-quarter from $1.0 in Q2 2025.
Analysis
Siga Technologies (SIGA) Capital Expenditures (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Capital Expenditures for 15 consecutive years, with $289576.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures rose 1191.19% year-over-year to $289576.0; the trailing twelve-month figure through Sep 2025 stood at $332308.0 (up 1250.19% YoY), and the FY2024 full-year result was $42450.0, up 95.75% from the prior year.
- Capital Expenditures rose to $289576.0 in Q3 2025 per SIGA's latest filing, from $1.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $289576.0 in Q3 2025 and bottomed at $1.0 in Q2 2025.
- Historically, Capital Expenditures has averaged $42922.6 across 4 years, with a median of $19762.0 in 2023.
- The widest YoY moves for Capital Expenditures: up 1191.19% in 2025, down 99.95% in 2025.
- Over 4 years, Capital Expenditures stood at $26196.0 in 2021, then decreased by 17.22% to $21686.0 in 2023, then decreased by 17.74% to $17838.0 in 2024, then soared by 1523.37% to $289576.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $289576.0, $1.0, and $24893.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 2.29 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 12.41 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 108.00 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 289,576.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 24,893.00 |
| Dec 31, 2024 | 17,838.00 |
| Sep 30, 2024 | 22,427.00 |
| Jun 30, 2024 | 2,185.00 |
| Jun 30, 2023 | 21,686.00 |
| Dec 31, 2021 | 26,196.00 |
| Jun 30, 2021 | 10,700.00 |
| Mar 31, 2021 | 13,724.00 |
| Mar 31, 2020 | 15,501.00 |
| Dec 31, 2019 | 2.00 |
| Sep 30, 2019 | 20,144.00 |
| Jun 30, 2019 | -3.00 |
| Mar 31, 2019 | 8,951.00 |
| Dec 31, 2018 | 74,401.00 |
| Jun 30, 2018 | 27,863.00 |
| Dec 31, 2017 | 45,882.00 |
| Sep 30, 2017 | 14,916.00 |
| Jun 30, 2017 | 39,326.00 |